MRM Health NV

Overview

• Industrybiotechnology¹
• HeadquartersGhent¹
• Legal formPublic limited company (Belgium)¹

See how the biggest companies compare on our leaderboards

MRM Health NV is a clinical-stage biopharmaceutical company that develops microbiome-based live biotherapeutic products for the treatment of chronic inflammatory diseases and to augment immune-oncology therapies. Founded in 2020 as a carve-out from ProDigest and a spin-off from the Flanders Institute for Biotechnology (VIB) and Ghent University.²

Timeline

1. 2019Founded Founded¹

Calendar

Drug trials and FDA: coming up

1. Sep 2027Phase 2 trial readout expected Phase 2 trial of Low-dose MH002 and High-dose MH002 in Colitis, Ulcerative: primary completion expected Sep 2027 (ClinicalTrials.gov NCT07296315).³

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Links

• WikipediaMRM Health NV
• WikidataQ137299589